Skip to main content

and
  1. No Access

    Article

    Adjuvant Therapy After Liver Resection for Colorectal Cancer Metastasis: What is the Evidence?

    Synchronous or metachronous liver metastases of colorectal origin (colorectal liver metastases, CLM), although being the expression of systemic disease, allow a curative approach for about 25% to 35% of patien...

    Dirk Arnold, Alexander Stein in Current Colorectal Cancer Reports (2011)

  2. No Access

    Article

    Should bevacizumab be continued beyond progression in colorectal cancer?

    Medical therapy for advanced colorectal cancer has seen significant changes over the past decade. Most recently, molecular targeted agents such as antibodies against the epidermal growth factor receptor and th...

    Axel Grothey, Dirk Arnold, Lee M. Ellis in Current Colorectal Cancer Reports (2008)